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Background: The prevalence of hyperuricemia has doubled worldwide during the last few decades. The substantial
increase in sweetened beverage (SB) consumption has also coincided with the secular trend of hyperuricemia.
Recent studies do show that the consumption of SB can induce hyperuricemia. However, the association between
SB and hyperuricemia remains unclear. The aim of this study was to evaluate the association between SB
consumption and levels of uric acid in Mexican adults.
Methods: We performed a cross-sectional analysis of data from selected adults participating in the baseline
assessment of the Health Workers Cohort Study. A total of 6,705 participants of both sexes between ages 18 and
70 years were included. SB intake was estimated using a validated semi-quantitative food frequency questionnaire.
Biochemical and anthropometric information was collected using standard procedures. Hyperuricemia was defined
as uric acid levels ≥ 7.0 mg/dL in men and ≥ 5.8 mg/dL in women. The association of interest was assessed by
multiple logistic regression models.
Results: The odds ratios (OR) for hyperuricemia in men who consume 0.5-1 SB/day was 1.59 (95% CI; 1.05-2.40) and
2.29 (95% CI; 1.55-3.38) for those who consume ≥3 SB/day when compared to men who consume less than half a
SB/day. In women, the OR for hyperuricemia for those who consume >1.0- < 3.0 SB/day was 1.33 (95% CI; 1.04-1.70)
and 1.35 (95% CI; 1.04-1.75) for those who consume ≥3 SB/day when compared to women who consume less than
half a SB/day, independent of other covariables. Men and women with high SB consumption and a body mass
index (BMI) ≥ 25 Kg/m2 had greater risk for hyperuricemia than men and women with low SB consumption and
normal BMI < 25 Kg/m2.
Conclusions: Our findings suggest that the consumption of SB is associated with an increased risk of hyperuricemia
in Mexican adults. However, longitudinal research is needed to confirm the association between SB intake and
hyperuricemia.
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The prevalence of hyperuricemia, defined as increased
serum uric acid levels [1], has doubled worldwide during
the last few decades [2]. Hyperuricemia is the precursor
of gout, which is the principal cause of inflammatory
arthritis among adult men and older women [3]. Hyper-
uricemia is furthermore recognized as an independent
risk factor for metabolic and cardiorenovascular conditions
including metabolic syndrome, type 2 diabetes (T2DM)
and insulin resistance [4-7]. In addition, epidemiological
evidence suggests that hyperuricemia may play a role in
epidemics of hypertension and coronary heart disease
[8,9]; however, recent evidence suggests no causal associ-
ation between uric acid and ischemic heart disease and
blood pressure [10]. The worldwide population-level in-
crease in serum uric acid levels over the past few decades
correlates with pronounced changes in the most prevalent
health risk factors known to be associated with hyperurice-
mina including: an increased prevalence of obesity and
metabolic syndrome as well as changes in dietary patterns
[11]. Studies suggest that foods such as alcohol, meat and
seafood play an important role in the development of hy-
peruricemia [12-14]. In general, a purine-rich diet has been
long recognized as a risk factor for hyperuricemia. Since
uric acid is the end product of purine degradation, gout
patients are advised to avoid purine-rich foods [15]. In con-
trast, dairy products and foods rich in vitamin C have been
shown to be protective against hyperuricemia [16]. Al-
though it is believed that diet plays an important role in
the development of hyperuricemia, the association between
other specific dietary factors or foods and hyperuricemia
remains unclear.
Recent studies do show that the consumption of
sugar-sweetened beverages (SB) can induce hyperurice-
mia [1,17,18]. Although these beverages do not contain
purines, they do contain large quantities of sweeteners
including sucrose (composed of 50% glucose and 50%
fructose), fructose and high fructose corn syrup (typic-
ally composed of 45% glucose and 55% fructose) [19].
Both fructose and high fructose corn syrup have been
associated with increased serum uric acid levels [20,21],
since uric acid production is upregulated by fructose,
unlike glucose and other monosaccharides [21]. The po-
tential mechanisms underlying the detrimental effects of
sucrose, fructose and high fructose corn syrup are under
debate. Some studies have suggested insulin resistance
as one of the mechanisms involved in hyperuricemia
[22,23]. One recent study suggests that long-term con-
sumption of fructose and high fructose corn syrup could
be a source of reactive dicarbonyls that increases risk of
metabolic disorders including hyperuricemia [24].
Mexico has one of the highest rates of SB consump-
tion in the world [4]. Reports indicate that SB consump-
tion among Mexican adults has increased to 21% of totalcaloric consumption from 1996 to 2006 [25,26], meaning
SB consumption is a significant component of the current
Mexican diet. For these reasons, a better understanding of
how fructose can affect plasma urate concentrations is
important if effective dietary recommendations are to be
formulated. Current recommendations include restriction
of alcohol, meat and other purine-rich foods, but planning
recommendations concerning SB should also be consid-
ered [27].
In this study we assess the potential health impact of
SB consumption by examining the relationship between
SB intake and uric acid levels in Mexican adults partici-
pating in the Health Workers Cohort Study. Because
earlier evidence [28] has suggested that body mass index
(BMI) may modify the effect of sweetened beverage on
gout or hyperuricemia, we also examined this relationship
stratifying by BMI and age.
Methods
Study population
A cross-sectional analysis was performed using data from
adults participating in the baseline evaluation of the ¨Health
Workers Cohort Study¨ (2004–2006). The methodology
and participant characteristics have been detailed previously
[29]. Of the 8,977 adults formally enrolled, for the present
analysis we used data from 8,514 participants aged 18 to
70 years, of which the following were excluded: pregnant
women (n = 186), those with a diagnosis of gout (n = 67),
those taking medications to control uric acid (n = 20), those
taking diuretics (n = 79), those without uric acid values
(n = 693), subjects that responded to less than 85% of ques-
tions or did not complete all the diet related questions (n =
525), subjects with extreme values of caloric intake (<600, >
7000 Kcal/day) (n = 87) using the standard deviation
method (>3.86SD) [30], subjects with outlying values of en-
ergy consumption from SB (n = 74), subjects not providing
information on tobacco use (n = 74) and subjects with in-
complete anthropometric data (n = 4). Ultimately, a total of
6,705 subjects were included in the analysis.
This study was planned and performed according to
the guidelines of the Declaration of Helsinki. All partici-
pating institutions’ research ethics committees [Comité
de Ética en Investigación, Instituto Mexicano del Seguro
Social (No. 12CEI 09 006 14); Comité de Ética en Inves-
tigación, Instituto Nacional de Salud Pública (No. 13CEI
17 007 36); Comité de Ética, Centro de Investigación en
Ciencias Médicas (No. 1233008X0236)], approved the
study protocol and informed consent forms. Written in-
formed consent was obtained from all participants.
Assessment of sugar- and artificially-sweetened beverage
consumption and other dietary intake
To assess diet, a validated semi-quantitative food frequency
questionnaire (FFQ) was used [31]. To test the FFQ’s
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val, to 134 women residing in Mexico city and the validity
results were then compared with those from the set of 4
recall tests given at 3 month intervals. The questionnaire
includes data describing the frequency of consumption of
116 foods during the previous year. This FFQ collects
information about the consumption of soft drinks, such
as: sugar-sweetened soft drinks (colas and other carbon-
ated beverages with sugar), flavored water with sugar
(such as lemon or orange water prepared with artificial
flavorings) and diet soft drinks (low-calorie colas and
other low-calorie beverages), using a standard serving
size of 355 ml. We also assessed consumption of orange
juice. The amount of energy intake from the ingestion
of these beverages (Kcal/serving) was determined using
the Evaluation System of Eating Habits and Nutrient
Consumption (SNUT) [32]. For this study, we summed
the intakes of single items to create totals for SB (sugar
sweetened soft drinks and flavored water with sugar)
and diet beverages (low-calorie colas and other low-calorie
beverages). In addition, SB intake was divided into four cat-
egories: (I) < 0.5 servings of SB/day, (II) ≥0.5 – 1.0 servings
of SB/day, (III) >1.0 - < 3 servings of SB/day, and (IV) ≥ 3
servings of SB/day. Total energy, energy from other carbo-
hydrates, nutrient intakes and alcohol consumption were
similarly estimated with this questionnaire.
Biological measures
A fasting venous blood sample was collected from the
antecubital vein; fasting time was ≥8 hours. Serum uric
acid levels were determined with the enzymatic colori-
metric method using the SYNCHRON CX® system [33].
Hyperuricemia was defined as uric acid levels ≥ 7.0 mg/
dL in men and ≥ 5.8 mg/dL in women [1].
Anthropometric measures
Body weight was measured with a previously calibrated
electronic scale (model BC-533; Tanita, Tokyo, Japan),
with participants wearing minimal clothing. Height was
measured using a conventional stadiometer (SECA brand),
on barefoot subjects standing with their shoulders in a nor-
mal position; measurements were taken with the tape in a
horizontal plane perpendicular to the vertical scale, touch-
ing the top of the head at the moment of inspiration. Waist
circumference was measured at the high point of the iliac
crest at the end of normal expiration, to the nearest
0.1 cm, with a conventional steel measuring tape (SECA
brand). Abdominal obesity was defined as a waist cir-
cumference > 102 cm for men and > 88 cm for women
[34]. Body mass index was classified as: normal (18.5
to < 25 kg/m2), overweight (≥25 to < 30 kg/m2), or obese
(≥30 kg/m2) [35]. The proportion of body fat was deter-
mined by dual X-ray absorptiometry (DEXA) using a
Lunar densitometer (model: DPX-GE 73735, serial number:638405U77) (Lunar Radiation Corporation, Madison, WI,
USA; software version .35, fast scan mode). Excess body fat
was defined as >35% in women and >25% in men [36].
All measurement procedures were performed by trained
personnel using standardized procedures.
Assessment of other variables
Demographic information was collected using a self-
administered questionnaire. Physical activity level was de-
termined using a survey used in similar follow-up studies
[37,38]. The participants reported the time they spent each
week on activities such as running, walking, etc. during a
typical week in the previous year. The physical activity vari-
able was categorized into: inactive <30 min/day and active
≥30 min/day, in accordance with previous studies [39]. Fi-
nally, participants were asked about weight changes they ex-
perienced during the previous year, and this information was
categorized as: no weight change, weight loss, or weight gain
in the past year. Participants who gained or lost less than
5 kg were categorized have experienced no weight change.
Statistical analysis
We performed an exploratory analysis by sex and SB in-
take considering the variables of age, body mass index,
body fat proportion, tobacco use, physical activity, levels
of uric acid, SB consumption and other dietary variables.
We used Student t tests for continuous variables and
Chi2 tests for categorical variables to test for differences
between sexes. When continuous variables did not show
a normal distribution, non-parametric tests for trends
across ordered groups were performed.
We assessed trends of acid uric levels, hyperuricemia,
and other variables across categories of SB intake. Differ-
ences between groups were computed with the test for
linear trend.
The effect of SB consumption on uric acid levels was
determined using linear regression models. In this case,
the increments of uric acid levels were considered across
categories of SB intake, using the lowest category of con-
sumption (<0.5 SB/day) as a reference.
To estimate the association between SB intake and levels
of uric acid, we computed odds ratios (OR) and 95% confi-
dence intervals (CI 95%) using multiple logistic regression
models, adjusting for different covariables in several models.
The first model was adjusted for age, the second added to-
bacco use, physical activity (min/day), and body weight
changes, the third model added energy intake (kcal/day),
alcohol consumption (g/day), percentage of energy from
carbohydrates (quintiles), total meats (servings/day), sea-
food (servings/day), total fruits (servings/day), dairy prod-
ucts (servings/day), coffee (cups/day), and vitamin C
intake (mg/day), and finally the fourth model added BMI
(kg/m2) to determine whether or not the relationship was
the result of a BMI classified as overweight or obese. In all
Table 1 Characteristics of Mexican adults from the







Age (years)Ş 42.6 (11.6) 43.0 (12.2) 0.1
18-27% 9.1 11.9 < 0.001
28-37 27.6 23.2 <0.001
38-47 29.4 29.4 0.9
48-57 22.3 22.3 0.9
58-70 11.6 13.2 0.1
BMI (kg/m2)Ş 27.1 (3.9) 26.7 (4.7) < 0.001
Overweight % Ω 50.6 38.9 < 0.001
Obese % Ω 19.1 20.4 0.2
Waist circumference (cm)Ş 93.7 (10.9) 89.7 (12.7) < 0.001
Central obesity % ¶ 20.1 53.0 < 0.001
Body fat proportion
by massŞ
30.3 (7.3) 42.6 (6.6) < 0.001
Excess (>25 M, >35 W), % 80.7 87.1 < 0.001
Physical activity (min/d)Ş 33.3 (39.0) 22.5 (28.5) < 0.001
Active (≥30 min/d), % 41.0 31.8 < 0.001
Tobacco use %
Ex-smoker 37.9 20.6 < 0.001
Current smoker 26.7 17.6 < 0.001
Uric acid (mg/dL)Ş 5.9 (1.5) 4.4 (1.2) < 0.001




1.8 (1.6) 1.6 (1.5) < 0.001
Portions of diet soft drinks 0.05 (0.2) 0.07 (0.3) 0.019
Portions of orange juice 0.36 (0.6) 0.42 (0.6) <0.001
Calorie intake from sweetened
beverages (Kcal/day)Ş
225 (198) 186 (184) < 0.001
Percent of energy intake
from sweetened beveragesŞ
9.5 (7.2) 8.5 (7.2) < 0.001
Total calorie intake (Kcal/day)Ş 2318 (925) 2146 (898) < 0.001
Carbohydrates (% of energy)Ş 59.0 (8.5) 61.1 (8.6) < 0.001
Fat (% of energy)Ş 20.3 (5.1) 20.5 (5.4) 0.2
Alcohol intake (gr/day) 9.2 (22.2) 2.2 (5.4) < 0.001
Total meat intake (servings/day)a 1.5 (1.0) 1.3 (0.9) < 0.001
Seafood intake (servings/day)b 0.15 (0.2) 0.14 (0.2) 0.05
Low fat dairy intake
(serving/day)c
0.48 (0.9) 0.56 (1.0) 0.002
High fat dairy intake
(servings/day)d
1.8 (1.6) 2.2 (2.1) < 0.001
Table 1 Characteristics of Mexican adults from the
baseline assessment of the Health Workers Cohort Study
(Continued)
Coffee intake (servings/day) 0.5 (0.9) 0.5 (0.9) 0.8
Total fruit intake (servings/day)e 3.7 (3.5) 5.1 (5.0) <0.001
Total vitamin C intake (mg/day)f 240.7 (206.6) 308.7 (261.8) <0.001
ŞValues are means and with SD in parentheses, unless otherwise specified;
Ω BMI: Overweight ≥ 25 - < 30 kg/m2; Obese, when BMI ≥ 30 kg/m2;
¶ Central obesity: > 102 cm in men and > 88 cm in women;
+ Hyperuricemia: ≥ 7.0 mg/dL for men, and ≥ 5.8 mg/dL for women;
aTotal meat included main or mixed dish of beef/pork/lamb/, processed meat
(sausage/bacon/ham/cecina/chorizo), poultry, chicken liver, beef liver, fried
pork chunks;
bSeafood intake included tuna, sardines, other seafood;
cLow fat dairy foods included skim/low fat milk and panela cheese;
dHigh fat dairy foods included whole milk, cream, butter, ice cream, cream
cheese, and other cheese.
eTotal fruit intake included banana, plum, peach, apple, orange, grapes,
strawberry, blackberry, melon, watermelon, mango, tangerine, pear, mammee
apple, sapote, prickly pear, papaya, pineapple;
fTotal vitamin C included dietary vitamin C and supplemental vitamin C;
*P < 0.05, difference in mean and proportion between sexes. Values were
determined using a student’s t-test for continuous variable and a chi2 test for
categorical variables.
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intake from SB was defined as < 0.5 SB/day.
To assess possible effect modification, we explored
analyses stratified by age (two categories: < 50 years
vs. ≥ 50 years), and BMI (two categories: <25 kg/m2
vs. ≥25 kg/m2). We tested the significance of the inter-
action with a likelihood ratio test by comparing a model
with the main effects of each intake and the stratifying
variable and the interaction terms with a reduced model
with only the main effects. All p values presented are
two sided; p < 0.05 was considered statistically signifi-
cant. All the statistical analyses were performed using
the STATA statistical software package, version 9.2 for
Windows (Stata Corp. LP: College Station, TX).
Results
The study population was made up of mainly middle-
aged participants; most (70.8%) were women with a
mean age of 43 years, and the rest were men with a
mean age of 42.6 years. Their average uric acid level was
5.9 mg/dL in men and 4.4 mg/dL in women (p < 0.001).
A total of 20.6% of men had hyperuricemia as compared
to 13.5% of women (p < 0.001). Men consumed an aver-
age of 225 kcal/day from SB, whereas women consumed
186 Kcal/day (p < 0.001) (Table 1).
Men with the highest SB intake (≥3 servings of SB/day)
were younger, had higher caloric and total carbohydrate
intakes and were more frequently smokers. Additionally,
the male participants with the highest SB intake had
higher average BMIs, proportions of obesity, and percent-
ages of body fat than men in the category with the lowest
SB intake (<0.5 servings of SB/day). Finally, serum uric
acid concentrations and hyperuricemia prevalence were
Table 2 Characteristics, according to categories of sugar-sweetened beverage intake by sex in a Mexican adult population
Men Women
< 0.5 SB/day ≥ 0.5-1.0 SB/day >1.0- < 3.0 SB/day ≥ 3 SB/day < 0.5 SB/day ≥ 0.5-1.0 SB/day >1.0- < 3.0 SB/day ≥ 3 SB/day
(n = 333) (n = 425) (n = 592) (n = 606) P value* (n = 1178) (n = 1063) (n = 1312) (n = 1196) P value*
Age (years)Ş 45.5 (12.0) 43.9 (11.8) 41.9 (11.4) 40.7 (11.0) < 0.001 45.8 (12.7) 43.3 (12.3) 42.2 (11.7) 41.0 (11.4) < 0.001
18-27% 5.0 7.9 10.4 10.8 0.003 9.5 12.2 12.7 13.2 0.004
28-37 22.3 24.8 28.7 31.4 0.003 19.5 22.6 23.6 27.1 < 0.001
38-47 28.2 30.2 28.9 30.0 0.6 25.8 28.8 31.0 31.7 0.001
48-57 27.3 22.4 22.1 19.8 0.01 24.4 22.9 22.5 19.3 0.003
58-70 17.2 14.7 9.9 8.0 < 0.001 20.8 13.5 10.2 8.7 <0.001
BMI (kg/m2)Ş 26.7 (3.8) 26.9 (4.0) 27.2 (4.0) 27.4 (3.8) 0.01 26.8 (4.8) 26.9 (4.7) 26.5 (4.6) 26.4 (4.7) 0.1
Overweight % Ω 50.5 52.8 49.1 50.6 0.9 39.4 37.9 38.1 40.3 0.6
Obese % 15.4 15.2 21.3 21.8 0.02 21.1 22.6 19.8 18.4 0.1
Body fat proportion 29.3 (6.9) 30.0 (7.6) 30.7 (7.8) 30.5 (6.7) 0.01 42.4 (6.7) 42.9 (6.5) 42.5 (6.7) 42.6 (6.5) 0.5
Excess body fat % ¶ 75.8 78.7 82.2 83.2 0.01 86.1 88.2 86.7 87.6 0.3
Physical activity (min/d)Ş 33.8 (37.5) 31.0 (37.7) 33.2 (39.2) 34.8 (40.6) 0.7 25.2 (30.0) 22.9 (29.9) 19.5 (25.7) 22.7 (28.4) 0.05
Active (≥30 min/d) % 42.9 37.6 40.3 43.1 0.9 35.2 32.0 27.9 32.6 0.2
Tobacco use %
Ex-smoker 40.1 42.1 37.3 34.4 0.1 22.1 19.4 19.8 21.0 0.5
Current smoker 16.3 20.1 30.6 33.2 < 0.001 13.2 14.8 20.4 21.1 < 0.001
Uric acid (mg/dL)Ş 5.7 (1.3) 5.8 (1.6) 5.9 (1.4) 6.1 (1.5) < 0 .001 4.3 (1.3) 4.4 (1.2) 4.4 (1.2) 4.4 (1.3) 0.9
Hyperuricemia %+ 13.4 19.2 20.8 25.2 < 0.001 13.1 13.8 14.1 14.1 0.9
Dietary variables
Portion of sweetened beverages/dayŞ 0.3 (0.4) 0.8 (0.4) 1.5 (0.7) 3.5 (1.6) < 0.001 0.3 (0.4) 0.8 (0.4) 1.5 (0.8) 3.5 (1.5) < 0.001
Calorie intake from sweetened
beverages (kcal/day)Ş
34.9 (26.8) 102.2 (41.8) 196.2 (89.4) 442.4 (195.9) < 0.001 28.9 (25.1) 96.8 (40.4) 180.2 (90.8) 426.4 (182.4) < 0.001
Total calorie intake (kcal/day)Ş 2214 (1004) 2250 (827) 2324 (929) 2416 (931) 0.002 2035 (934) 2155 (840) 2111 (916) 2309 (871) < 0.001
Carbohydrates (% of energy)Ş 56.9 (10.0) 57.2 (8.1) 57.8 (7.7) 62.7 (7.3) < 0.001 59.5 (10.0) 59.4 (8.0) 60.2 (7.6) 65.1 (7.4) < 0.001
Protein (% of energy)Ş 17.9 (7.7) 17.7 (6.0) 17.8 (6.0) 15.6 (4.9) <0.001 15.0 (5.6) 15.2 (4.8) 15.2 (4.6) 13.0 (3.9) < 0.001
Fat (% of energy)Ş 25.2 (6.1) 25.1 (5.3) 24.4 (4.9) 21.7 (4.6) < 0 .001 24.5 (6.5) 25.4 (5.2) 24.5 (4.8) 21.8 (4.9) < 0.001
Alcohol intake (gr/day) 10.2 (40.9) 9.3 (17.1) 10.0 (17.7) 7.7 (12.6) 0.18 2.1 (5.2) 2.5 (6.3) 2.0 (5.4) 2.1 (4.8) 1.00
Total meat intake (servings/day)a 1.45 (1.3) 1.47 (0.9) 1.54 (0.9) 1.46 (0.9) 0.88 1.19 (1.0) 1.33 (0.9) 1.32 (0.9) 1.26 (0–8) 0.06
Seafood intake (servings/day)b 0.20 (0.33) 0.15 (0.17) 0.13 (0.15) 0.13 (0.18) < 0.001 0.15 (0.25) 0.15 (0.19) 0.13 (0.22) 0.12 (0.30) 0.08
Low fat dairy intake (serving/day)c 0.62 (1.0) 0.53 (1.0) 0.46 (0.8) 0.39 (0.8) < 0.001 0.70 (1.1) 0.60 (1.0) 0.48 (0.9) 0.47 (0.9) <0.001




















Table 2 Characteristics, according to categories of sugar-sweetened beverage intake by sex in a Mexican adult population (Continued)
Coffee intake (servings/day) 0.44 (0.9) 0.47 (0.9) 0.54 (0.9) 0.55 (0.9) 0.05 0.44 (0.8) 0.46 (0.8) 0.58 (0.9) 0.57 (0.9) <0.001
Total fruit intake (servings/day)e 4.8 (5.2) 3.9 (4.2) 3.6 (3.9) 3.1 (3.5) <0.001 6.0 (6.4) 5.4 (5.3) 4.7 (5.0) 4.5 (4.5) < 0.001
Total vitamin C intake (mg/day)f 278 (256) 237 (185) 230 (199) 230 (196) 0.001 330 (298) 303 (239) 287 (256) 317 (247) 0.24
ŞValues are means and with SD in parentheses, unless otherwise specified;
Ω BMI: Overweight ≥ 25 - < 30 kg/m2; Obese, when BMI ≥ 30 kg/m2;
¶ Central obesity: > 102 cm in men and > 88 cm in women;
+ Hyperuricemia: ≥ 7.0 mg/dL for men, and ≥ 5.8 mg/dL for women;
aTotal meat included main or mixed dish of beef/pork/lamb/, processed meat (sausage/bacon/ham/cecina/chorizo), poultry, chicken liver, beef liver, fried pork chunks;
bSeafood intake included tuna, sardines, other seafood;
cLow fat dairy foods included skim/low fat milk and panela cheese;
dHigh fat dairy foods included whole milk, cream, butter, ice cream, cream cheese, and other cheese.
eTotal fruit intake included banana, plum, peach, apple, orange, grapes, strawberry, blackberry, melon, watermelon, mango, tangerine, pear, mammee apple, sapote, prickly pear, papaya, pineapple;
fTotal vitamin C included dietary vitamin C and supplemental vitamin C;




















Table 3 Differences in serum uric acid levels (mg/dL) according to categories of sugar-sweetened beverage intake
Men Women**









β (95% CI) β (95% CI) β (95% CI) β (95% CI) P-value* β (95% CI) β (95% CI) β (95% CI) β (95% CI) P-value*




















































*P for linear trend.
Model I: adjusted for age (18–27, 28–37, 38–47, 48–57, 58–70 years of age);
Model II: adjusted for tobacco use (Current smoker, ex-smoker y non-smoker), physical activity (active ≥30 min/d, inactive < 30 min/d), weight change (did not
gain, gained, lost);
Model III: adjusted for calorie intake (quintiles),total meats (servings/day), seafood (servings/day), dairy products (servings/day), alcohol intake (g/day), total fruits
(servings/day), vitamin C intake (mg/day), coffee (cups/day);
Model IV: BMI (normal <25 kg/m2, overweight/obesity ≥25 kg/m2);
**For women, model IV was additionally adjusted for menopause (%) and postmenopausal hormone use (%).
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trend <0.001). For the female participants, women in the
highest category of SB consumption were more frequently
smokers and were less active than women in the lowest
category of SB consumption (Table 2).
The results of a multivariate regression analysis evalu-
ating the effect of sweetened beverage intake on uric
acid levels are presented in Table 3. In the adjusted model,
we found that uric acid levels in men who consumed
more than 3 servings of sweetened beverages per day in-
creased 0.38 mg/dL (P < 0.001); whereas in women these
levels increased to 0.21 mg/dL, in comparison with sub-
jects who consumed less than 0.5 servings of SB/day.Table 4 Odds ratios (95% CI) for hyperuricemia according to
Men





OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) P-valu




























*P for linear trend.
Model I: adjusted for age (18–27, 28–37, 38–47, 48–57, 58–70 years of age);
Model II: adjusted for tobacco use (Current smoker, ex-smoker y non-smoker), phys
gain, gained, lost);
Model III: adjusted for calorie intake (quintiles),total meats (servings/day), seafood (s
(servings/day), vitamin C intake (mg/d), coffee (cups/day);
Model IV: BMI (normal <25 kg/m2, overweight/obesity ≥25 kg/m2);
**For women, model IV was additionally adjusted for menopause (%) and postmenResults of the multiple logistic regression analysis show
a positive association between SB consumption and the
presence of hyperuricemia in men and women. In men
consuming ≥0.5 - 1.0 servings of SB/day, the multivariate
odds ratio for hyperuricemia was 1.59 (95% CI: 1.05–2.40),
as compared with the reference consumption level of SB
(<0.5 servings of SB/day). For men consuming >1.0 - <3.0
servings of SB/day, this was 1.68 (95% CI: 1.14–2.49), and
men consuming ≥ 3.0 SB/day was 2.29 (95% CI: 1.55–3.38;
p for trend <0.001). For women, the ORs for hyperurice-
mia across categories of SB consumption were: 1.19 (95%
CI: 0.92-1.53), 1.33 (95% CI: 1.04-1.70) and 1.35 (95% CI:
1.04-1.75) p for trend 0.015 (Table 4).categories of energy of sweetened beverage intake
Women**


































ical activity (active ≥30 min/d, inactive < 30 min/d), weight change (did not
ervings/day), dairy products (servings/day), alcohol intake (g/d), total fruits
opausal hormone use (%).
(A) (B)
Figure 1 Multivariate odds ratio of hyperuricemia in men, according to the tertiles of sweetened beverage intake. *Analyses of effect
modification: (A) stratified by body mass index (BMI: < 25 kg/m2 vs ≥ 25 kg/m2), (B) stratified by age (< 50 years vs ≥ 50 years. Reference group
for comparisons was men in lowest tertile of sweetened beverage intake and (A) with body mass index < 25 kg/m2, and (B) with age < 50 years.
Odds ratio were adjusted for: age (years), tobacco use (current smoker, ex-smoker y non-smoker), physical activity (active ≥ 30 min/day, inactive < 30
min/day), weight change (did not gain, gained, lost), calorie intake (quintiles), percentage of energy from total carbohydrate (quintiles), percentage of
energy from protein (quintiles), alcohol intake (gr/day), vitamin C intake (mg/day), and body mass index.
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http://www.biomedcentral.com/1471-2458/14/445We examined the joint effect of SB intake and body
mass index by cross classifying the study population by
both variables. The odds ratio from these stratified ana-
lyses was 4.71 (95% CI: 2.64-8.36; p for interaction 0.007)
when men with high SB consumption and overweight/
obesity were compared with men with a low consumption
of sweetened beverage and body mass index < 25 kg/m2
(Figure 1A). In women (Figure 2A), the OR for the com-
bination of a high consumption of SB and BMI ≥ 25 kg/
m2 compared with women in the opposite extreme was
3.77 (95% CI: 2.53-5.35, p for interaction 0.007).
Discussion
Our results suggest that a considerable portion of our
male participants’ energy consumption came from SB(A)
Figure 2 Multivariate odds ratio of hyperuricemia in women, accordin
modification: (A) stratified by body mass index (BMI: < 25 kg/m2 vs. ≥ 25 k
for comparisons was women in lowest tertile of sweetened beverage intak
years. Odds ratio were adjusted for: age (years), tobacco use (current smok
inactive < 30 min/d), weight change (did not gain, gained, lost), calorie int
percentage of energy from protein (quintiles), alcohol intake (g/d), vitamin(9.5%). This result is consistent with previous reports that
estimate the daily energy intake from SB among Mexican
adults (10%) [4,26]. We found that men consumed an
average of 225 Kcal/day and women consumed 186 Kcal/
day from SB. These findings suggest that excessive SB
consumption is contributing to excess calorie intake [25],
supporting recommendations to minimize daily SB con-
sumption. These recommendations are further supported
given that our study population exceeded the recom-
mended calorie intake limit (220 Kcal/day for men and
180 Kcal/day for women) established for the Mexican
population by a committee of experts [26].
According to our results, increased SB intake is posi-
tively associated with increased risk of hyperuricemia in
Mexican adults, independent of other covariables. The(B)
g to the tertiles of sweetened beverage intake. *Analyses of effect
g/m2), (B) stratified by age (< 50 years vs. ≥ 50 years. Reference group
e and (A) with body mass index < 25 kg/m2, and (B) with age < 50
er, ex-smoker y non-smoker), physical activity (active ≥ 30 min/d,
ake (quintiles), percentage of energy from total carbohydrate (quintiles),
C intake (mg/d), and body mass index.
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http://www.biomedcentral.com/1471-2458/14/445prevalence of hyperuricemia in our study (20.6% of men,
13.5% of women) is similar to that reported in a cross-
sectional analysis completed by Choi et al. (19% of men,
17% of women) in the US using information from the
Third US National Health and Nutrition Examination
Survey, in which the association between SB consump-
tion and levels of uric acid was analyzed [1].
In this study, Choi et al. reports that the subjects con-
suming more than 4 SB/day had an 82% increased risk
of hyperuricemia (OR = 1.82; p = 0.003) in comparison
with those that did not consume SB [1]. In our results,
the risk of hyperuricemia increased significantly with an
intake of SB greater than 3 SB/day, leading to 129% in-
creased odds of hyperuricemia in men and 35% increased
odds of hyperuricemia in women compared with partici-
pants who consumed less than 0.5 servings of SB/day.
In this study, we observed that men and women with
high SB consumption and a body mass index ≥ 25 Kg/m2
are respectively at approximately 5.0 and 4.0 times greater
risk for hyperuricemia than men and women with low SB
consumption and normal body mass index, independent
of dietary and other risk factors. Obesity is associated with
hyperuricemia [40], and also positively and independently
associated with clinical conditions commonly related to
hyperuricemia including insulin resistance, hypertension,
and inflammation [41].
The effect of SB consumption on uric acid levels may
be explained by changes resulting from the ingestion of
sucrose and fructose. During the metabolism of fructose,
it is phosphorylated to fructose-1-phosphate (F1P) by
fructokinase. The depletion of adenosine triphosphate
(ATP) inhibits the oxidative phosphorylation of adeno-
sine diphosphate (ADP) by creating a shortage of inor-
ganic phosphate (Pi). As a result, F1P is sequestered and
the ADP produced during this metabolic cycle is con-
verted into adenosine monophosphate (AMP) by adenyl-
ate kinase, which can also serve as a substrate for the
production of uric acid. Moreover, the depletion of ATP
and Pi during the metabolism of fructose decreases feed-
back inhibition for the generation of uric acid. Indeed, ex-
perimental studies in humans and animals show a short
term rise in acid uric concentrations with subsequent
fructose ingestion or infusion [20,21]. Fructose may also
indirectly increase serum levels of uric acid by increasing
insulin resistance, leading to impaired glucose tolerance,
and elevated circulating insulin levels [18,20,21,42,43].
Our findings have important implications for the pre-
vention of hyperuricemia. Our results provide evidence
that SB poses an increased risk for hyperuricemia. This
casts doubt on the adequacy of the current dietary recom-
mendations of the Mexican public health system aimed at
reducing SB consumption. New health policies are neces-
sary. While obesity is an important risk factor for T2DM,
and other metabolic complications, there is new evidencesuggesting that elevated uric acid levels is one of the most
important risk factors for cardiovascular disease and also
plays an important role in the development of renal dis-
ease [5], T2DM metabolic syndrome, and insulin resist-
ance [44,45], which are important public health problems
in Mexico.
There are some potential limitations of our study. First,
the cross-sectional design of the study does not allow for
identification of a causal relationship between SB intake
and the occurrence of hyperuricemia, since the temporal
relationship of these events cannot be determined. The re-
lationship between high SB consumption and hyperurice-
mia is, however, biologically plausible, and will need to be
confirmed in future longitudinal studies. Second, this co-
hort population cannot be considered representative of
the Mexican population as a whole, but instead only rep-
resentative of adults living in urban areas in central
Mexico. Finally, even though many studies, including ours,
used ≥ 7 mg/dL for men and ≥ 5.8 mg/dL for women as a
cut-off to identify hyperuricemia, there is no consensus on
the acid uric level cut-off point for identifying hyperurice-
mia. In spite of these limitations, the main strength of this
study was the large number of participants.
Conclusion
Our findings support a positive association between SB
intake and serum uric acid levels in Mexican adults. If
this relationship is causal, it could inform approaches for
preventing chronic diseases such as T2DM, hypertension,
gout, and cardiovascular disease. This evidence further-
more suggests the need to implement health policies for
reducing SB consumption in Mexico. Longitudinal re-
search is needed to confirm the association between SB in-
take and hyperuricemia. Further studies are also required
to elucidate the risk of hyperuricemia among high SB con-
suming overweight/obese individuals and the elderly.
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